Article
CEQA Reform Qualifies For The Ballot: What To Know About The Building An Affordable California Act
California voters will decide on Proposition 45 this November, a sweeping initiative that would fundamentally reshape environmental review for housing, infrastructure, and other essential projects across the state. The Building an Affordable California Act promises faster approvals and limited judicial challenges, but faces organized opposition from labor unions and environmental groups. Will this measure succeed in streamlining development, or does it go too far in curtailing environmental protections?
United States Environment
RT
Rutan & Tucker
Podcast
S6:E11 | A Comprehensive Look At Ponzi Schemes – Lessons From The Front Lines | Compliance In Context (Podcast)
Welcome back to the Compliance In Context podcast! On today’s show, we will be providing a comprehensive, deep-dive look at Ponzi schemes—what are they, historical facts and impact, themes and trends, and some best practices to keep in mind to help prevent these types of frauds from occurring inside your firms and with any underlying clients.
United States Criminal
CH
Calfee Halter & Griswold
See more

Mondaq's Must Reads

Trending This Week on Mondaq

Highlighted Content

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology..

Article
Teva And Polpharma Biologics Announce Global Licensing Agreement For Ocrelizumab Biosimilar For Multiple Sclerosis
Teva Pharmaceuticals and Polpharma Biologics have entered into a global licensing agreement for the commercialization of a biosimilar candidate to Genentech's OCREVUS (ocrelizumab), a treatment for multiple sclerosis. The agreement combines Polpharma Biologics' development expertise with Teva's commercial capabilities across major markets including the United States, Europe, and several other territories. Under the terms, Polpharma Biologics will handle development and manufacturing while Teva manages regul
United States Healthcare
GP
Goodwin Procter LLP
See more

Covers Donald Trump's Presidency, providing expert thought leadership across the various legal practice areas that may be impacted.

Including but not limited to Employment and HR, Immigration, International Law, Environment Law and Technology.

Article
Client Spotlight Interview: Alsym Energy
Alsym Energy CEO Mukesh Chatter discusses the company's innovative sodium-ion battery technology designed to revolutionize energy storage through enhanced safety, cost-effectiveness, and supply chain independence. The conversation explores how physics-informed AI accelerates battery development, the critical role of non-flammable storage in AI data centers and grid infrastructure, and the strategic advantages of building a fully domestic battery supply chain using abundant materials like sodium and iron.
United States Energy
FH
Foley Hoag LLP
Article
Trump Administration Rescinds The Definition Of “Harm” Under The Endangered Species Act
The United States Fish and Wildlife Service and National Marine Fisheries Service have rescinded the regulatory definition of "harm" under the Endangered Species Act, fundamentally altering how habitat modification is treated under federal wildlife protection law. This rule eliminates the long-standing interpretation that habitat destruction causing injury or death to listed species constitutes prohibited "take," potentially reducing liability for land development activities. The change follows the Supreme
United States Environment
RT
Rutan & Tucker
See more